| Financial Year |
March 31 2023 |
| Monetary Funds |
656,211,893.34 |
| Held-for-trading Financial Assets |
1,110,408,654.30 |
| Notes Receivable |
87,399,540.75 |
| Accounts Receivable |
1,785,529,718.71 |
| Advances to Suppliers |
116,471,767.18 |
| Other Receivables |
23,313,811.87 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,851,799,082.56 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
46,555,768.84 |
| Total Current Assets |
6,001,071,537.25 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
123,612,561.95 |
| Investment Properties |
82,956,740.98 |
| Fixed Assetes |
838,940,760.48 |
| Under-construction Projects |
425,666,273.85 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
292,375,886.35 |
| R&D expenses |
-- |
| Goodwill |
98,503,965.98 |
| Long-Term Deferred and Prepaid Expenses |
40,953,579.43 |
| Deferred Income Tax Assets |
83,378,117.74 |
| Other Non-Current Assets |
187,598,745.54 |
| Sub-Total of Non-Current Assets |
2,855,661,767.33 |
| Total Assets |
8,856,733,304.58 |
| Short-Term Loans |
376,886,176.11 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,166,593,632.08 |
| Accounts Payable |
1,662,775,479.32 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
227,138,529.33 |
| Taxes Payable |
51,098,069.90 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
31,334,440.52 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
31,541,315.83 |
| Other Current Liabilities |
48,552,137.18 |
| Sub-Total of Current Liabilities |
3,655,811,512.93 |
| Long-term Loans |
-- |
| Bonds Payable |
1,042,236,482.03 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
12,983,427.79 |
| Deferred Income Tax Liabilities |
55,512,329.10 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,202,477,227.46 |
| Total Liabilities |
4,858,288,740.39 |
| Paid-In Capital(Or Share Stock) |
497,569,343.00 |
| Capital Surplus |
1,045,653,254.78 |
| Surplus Reserve |
122,465,628.67 |
| LESS:Treasury Stock |
69,994,546.36 |
| Undistributed Profits |
2,076,467,515.36 |
| Minority Stockholder's Interest |
127,960,853.94 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,870,483,710.25 |
| Owner's Equity（Stockholder's Equity） |
3,998,444,564.19 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,856,733,304.58 |
